©2022 Stanford Medicine
Attain Performa(TM) Quadripolar Lead Study
Recruiting
I'm InterestedTrial ID: NCT01751022
Purpose
The purpose of the study is to evaluate the safety and efficacy of the Medtronic Attain
Performa Quadripolar Leads (Model 4298, 4398, and 4598) during and post the implant
procedure. This study will also assess the interactions of the Attain Performa leads with the
entire Medtronic CRT-D system.
Official Title
Attain Performa(TM) Quadripolar Lead Study
Stanford Investigator(s)
Marco Perez
Associate Professor of Medicine (Cardiovascular Medicine)
Eligibility
Inclusion Criteria:
- Patient is indicated for implant of a CRT-D device and left-heart lead per local
indications (In US only this is based on Class I and II indications for CRT-D implant
per HRS/ACC/AHA guidelines)
- Patient (or legally authorized representative) has signed and dated the study-specific
Consent Form
- Patient is 18 years of age or older, or is of legal age to give informed consent per
local and national law
- Patient is expected to remain available for follow-up visits
- Patient understands the study and agrees to comply with study protocol
Exclusion Criteria:
- Patient has a previous LV lead implanted or previous implant attempt within 30 days of
enrollment or has ongoing AEs from a previous unsuccessful implant attempt
- Patient has contraindications for standard transvenous cardiac pacing (e.g.,
mechanical right heart valve)
- Patient has had a heart transplant (Note: Patients waiting for heart transplants are
allowed in the study)
- Patient is contraindicated for < 1 mg dexamethasone acetate
- Patient is currently enrolled or planning to participate in a potentially confounding
drug or device study during the course of this study. (Note: Co-enrollment in
concurrent studies may be allowed provided that documented pre-approval is obtained
from Medtronic's study manager)
- Patient has a life expectancy less than 180 days
- Patient with exclusion criteria required by local law (e.g. age, pregnancy, breast
feeding, etc.)
- In US, women of childbearing potential must have a negative pregnancy test 7 days
prior to implant to be included
- Patient is unable to tolerate an urgent thoracotomy
Intervention(s):
device: Device: Attain Performa Pacing Lead (along with a standard CRT-D system)
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Linda Norton, RN, MSN
(650) 725-5597